pseudomyxoma peritonei (Cancer)

Search with Google Search with Bing
Information
Disease name
pseudomyxoma peritonei
Disease ID
DOID:3559
Description
"An appendix cancer that is characterized by progressive accumulation of mucus-secreting tumor cells within the abdomen and pelvis." [url:http\://en.wikipedia.org/wiki/Pseudomyxoma_peritonei, url:http\://www.cancer.gov/dictionary?CdrID=44256, url:http\://www.rarediseases.org/rare-disease-information/rare-diseases/byID/843/viewAbstract, url:https\://www.ncbi.nlm.nih.gov/pubmed/14567019]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02387203 Active, not recruiting Phase 2 Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin January 2015 December 2024
NCT02834013 Active, not recruiting Phase 2 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors January 30, 2017 May 1, 2026
NCT01764789 Completed N/A Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer October 2010 January 2012
NCT02040142 Completed Phase 2 Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C November 2011 November 9, 2020
NCT01126346 Completed N/A Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May 2010 October 2013
NCT01652794 Completed Phase 1 Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer May 2012 March 2015
NCT02374411 Completed Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients September 2014 March 2015
NCT02949791 Completed Phase 2 HIPEC Using High Intra-abdominal Pressure December 2014 November 2017
NCT03034850 Completed Thrombin Generation and Platelet Activation in CRS/HIPEC April 2015 July 2016
NCT04088786 Completed Phase 1 Phase I Trial HIPEC With Nal-irinotecan October 22, 2019 April 14, 2022
NCT05513183 Completed Severe Neutropenia After HIPEC Using Mitomycin-C May 20, 2021 March 20, 2023
NCT06084780 Not yet recruiting Phase 2 Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) October 2024 December 31, 2025
NCT02599116 Recruiting N/A Gastrointestinal Microbiome Study of Appendiceal Cancer December 2015 December 2024
NCT02073500 Recruiting Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies September 2009 August 2027
NCT01617382 Recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed May 2012 December 2026
NCT04024917 Recruiting N/A Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis September 21, 2021 June 2025
NCT04665921 Terminated Phase 1 A Study of SGN-STNV in Advanced Solid Tumors January 18, 2021 March 1, 2024
NCT01427101 Unknown status Results of CRS and Debulking in PMP Patients September 1993
NCT04982146 Unknown status Phase 1 Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei September 13, 2021 May 16, 2023
NCT05321329 Unknown status Phase 2 Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients December 3, 2018 December 2023
NCT03210298 Unknown status International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) January 2016 September 2022
NCT03976973 Unknown status Phase 2 BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei May 2022 February 2024
NCT02834169 Unknown status French National Registry of Rare Peritoneal Surface Malignancies October 2010 December 2018
NCT04125225 Withdrawn What Are the Experiences of Patients With Pseudomyxoma Peritonei? November 1, 2019 February 1, 2021
Disase is a (Disease Ontology)
DOID:11239
Cross Reference ID (Disease Ontology)
GARD:7488
Cross Reference ID (Disease Ontology)
ICDO:8480/6
Cross Reference ID (Disease Ontology)
MESH:D011553
Cross Reference ID (Disease Ontology)
NCI:C3345
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:307601000
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0033822
Exact Synonym (Disease Ontology)
mucinous Ascites
OrphaNumber from OrphaNet (Orphanet)
26790
MeSH unique ID (MeSH (Medical Subject Headings))
D011553